Andrew Evens, DO, MBA, MSc, currently serves as the deputy director for clinical services at Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center. Additionally, he acts as the system director of medical oncology at RWJBarnabas Health Medical Group.
Expanding Resources, Clinical Knowledge to Enhance AYA NHL Care: Andrew Evens, DO
May 2nd 2025To better treat adolescent and young adult (AYA) patients with various subtypes of Hodgkin and non-Hodgkin lymphomas (NHL), Andrew Evens, DO, speaks to the importance of primary care, screening access, and research.
Limited Clinical Insight Poses Barrier to Optimal NHL Treatment: Andrew Evens, DO
April 7th 2025Clinical approaches to non-Hodgkin lymphoma in younger and older patient groups generally do not differ, according to Andrew Evens, DO, but he emphasized the need for deeper clinical insights into potential biologic differences in younger oncology patients.